One-liner: “ArteraAI develops AI tests for personalized cancer therapy, focusing on prostate cancer treatment for healthcare providers and patients.”
Company slogan: “A leading precision medicine company, Artera develops AI-enabled tests to help personalize therapy for cancer patients.”
Positioning: “ArteraAI is positioned as a pioneer in personalized cancer therapy through the use of multimodal AI tests, specifically targeting prostate cancer treatment.”
Description: Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.
Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.
Employees: 108
Website: Visit websiteHeadquarters: “Los Altos, California”
Ownership: Privately Held
Founded: –
Company type: AI company
Use cases: “AI in cancer therapy, personalized medicine, prostate cancer treatment”
Pricing: CMS payment rate established for ArteraAI prostate cancer test
Client sector: healthcare
Business model: subscription
Products: ArteraAI Prostate Test
Is API available: no
Website title: Arteria AI
Website description: Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
Linkedin: https://www.linkedin.com/company/arteraai
Youtube: –
Instagram: –
Facebook: –
Twitter: https://twitter.com/arteraAI
Crunchbase: https://www.crunchbase.com/organization/artera-98e6
Email: –